StockData
Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock

RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.45−0.02 (-4.36%)

Close on Oct 19, 2026Market cap $5.94MP/E –Yield –

Reviva Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Reviva Pharmaceuticals's enterprise value was -$13.85M on Oct 19, 2026, against $31.58M a year earlier. Over the last 5 years it ranged from -$16.72M to $125.14M, with a median of $28.28M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026-$13.85M-196.3%
2025Dec 31, 2025$14.38M-74.6%
2024Dec 31, 2024$56.60M-45.7%
2023Dec 29, 2023$104.33M+58.3%
2022Dec 30, 2022$65.92M+964.1%
2021Dec 31, 2021$6.19M-75.4%
2020Dec 31, 2020$25.15M–

More Reviva Pharmaceuticals figures

See a number that looks wrong?